Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | TLXTelix Pharmaceuticals LtdFY2025 · Dec |
|---|---|
| Revenue | $803.79M |
| Revenue, yoy | +55.6% |
| Net income | $7.13M |
| Net income, yoy | −121.2% |
| Net margin | -0.9% |
| Free cash flow | $42.99M |
| FCF margin | -5.3% |
| EPS, diluted | $0.02 |
Add another company.